8VC is a venture capital firm founded in 2012 and headquartered in Austin, Texas, with additional presence in San Francisco. The firm focuses on investing in transformative technologies across various sectors, including healthcare, logistics, IT infrastructure, biology, and government and defense. 8VC aims to partner with founders to drive innovation and create long-term economic and societal value. The firm is dedicated to enabling industry transformation by investing in emerging platforms that have the potential to replace outdated technology infrastructures, thereby fostering greater innovation and global prosperity. As a Registered Investment Adviser, 8VC is committed to its mission of supporting companies that can significantly impact their respective industries.
Think it, speak it, send it. Effortless voice dictation for Mac and now Windows!
Patlytics
Seed Round in 2024
Patlytics is a developer of an artificial intelligence-powered platform that streamlines the entire patent lifecycle. The platform provides a range of features, including patent drafting, prosecution, litigation readiness, competitive landscape analysis, and real-time alerts and reports. By leveraging advanced technology, Patlytics enhances patent workflow efficiency, helping businesses to effectively manage their intellectual property portfolios and maintain a competitive edge in the market.
Unlearn.AI
Series C in 2024
Unlearn.AI, Inc. is a biotechnology company that specializes in developing software tools for clinical research, focusing on improving diagnosis and treatment processes. Based in San Francisco, the company offers solutions such as Clinical Trial Design, which helps define inclusion criteria, endpoints, and study sizes; Synthetic Control Arms, which reduce or eliminate the necessity for concurrent control groups; and Subgroup Analysis, which identifies specific patient subgroups within trial results. Unlearn.AI has pioneered the TwinRCT solution, a digital twin service that leverages machine learning to enhance the efficiency and success rates of clinical trials. This innovative approach creates a prognostic digital twin for each patient, allowing for more precise estimations of treatment effects based on historical data. By integrating machine learning and biostatistics, Unlearn.AI aims to accelerate the clinical trial process, benefiting both patients and pharmaceutical sponsors.
LightBeam.ai
Series A in 2024
LightBeam.ai is a leader in data security and privacy automation, dedicated to helping organizations manage and access sensitive information securely. The company offers a platform that utilizes advanced data management, entity linkage techniques, and deep learning to analyze documents, speech, and natural language processing at scale. This technology integrates seamlessly with various data sources across industries, enabling clients to derive actionable insights while maintaining data privacy and confidentiality. By providing a unified control tower for data cataloging, access, and sharing, LightBeam empowers privacy and compliance executives to ensure continuous compliance, while information security professionals can trust that sensitive data is accessed and utilized securely.
Coram AI
Seed Round in 2023
Coram AI develops video intelligence systems aimed at enhancing business operations. The company offers a platform that transforms standard cameras into intelligent systems, providing valuable insights into various aspects of daily operations, including safety and security. By leveraging this technology, businesses of all sizes can gain fresh perspectives on their processes and make informed decisions that drive operational improvements. Coram AI's innovative approach allows clients to utilize their existing camera infrastructure more effectively, turning passive video recording into an active tool for operational enhancement.
SapientAI
Seed Round in 2023
SapientAI created AI Test Coder, the first platform that combines contextual insights, coding intelligence, and generative AI to generate correct test code for software developers.
DevEfficiency
Seed Round in 2023
DevEfficiency has developed AI Test Coder, a groundbreaking platform that integrates contextual insights and coding intelligence to produce accurate test code.
Tome
Series B in 2023
Tome is a company that transforms the sales process for teams by utilizing custom language models to enhance productivity at every stage of sales. The platform aids sales representatives in building qualified pipelines through detailed account research, value hypotheses, and automated outreach. It accelerates existing sales efforts by providing automated call summaries, updated account plans, CRM synchronization, and auto-generated marketing collateral. Additionally, Tome offers insights that help optimize sales strategies, enabling teams to identify effective messaging and features that lead to quicker, larger deals. By streamlining repetitive tasks, Tome allows account executives to focus more on customer interactions, while sales leaders benefit from improved pipeline quality and deal closure rates. Revenue operations leaders can trust that their systems are functioning efficiently, maximizing the potential of their sales processes.
Spartan Radar
Series B in 2023
Spartan Radar specializes in advanced radar technology that creates high-resolution real-time imagery, utilizing proprietary software algorithms that incorporate machine learning and edge-processing. By mimicking human sensory perception, Spartan's solutions enhance the performance of existing advanced driver-assistance systems (ADAS) by improving resolution, response time, and range while maintaining low computational demands. The company's expertise in signal processing, developed through years of experience in the aerospace and automotive sectors, enables it to offer cost-effective sensing solutions. Spartan's platform is applicable across various industries, including drone and automotive applications, positioning the company as a leader in innovative radar technology.
Atomic AI
Series A in 2023
Atomic AI is focused on advancing RNA drug discovery through the integration of machine learning and structural biology. The company operates a content intelligence platform that facilitates the rational design of new molecules and medicines. By leveraging engagement data from clients' analytics, Atomic AI gathers insights to create predictive reports on various topics, including optimal publishing times and distribution channels. This approach equips users with innovative strategies to develop treatments or cures for diseases by specifically targeting RNA structures.
Wispr Flow
Seed Round in 2022
Think it, speak it, send it. Effortless voice dictation for Mac and now Windows!
Rephrase.ai
Series A in 2022
Rephrase.ai specializes in an AI-powered video creation technology that transforms text into animated videos featuring realistic facial representations of individuals. This innovative approach employs generative AI to analyze and learn the facial features of specific people in relation to spoken audio, allowing the system to create photorealistic visuals for any new text or audio input. The platform serves a variety of applications, enabling clients to produce training videos, personalize sales presentations, animate characters in augmented and virtual reality, and provide a visual identity for digital assistants. Through its advanced technology, Rephrase.ai enhances the way organizations communicate and engage with their audiences.
Digital Diagnostics
Series B in 2022
Digital Diagnostics Inc. is an artificial intelligence diagnostics company focused on enhancing the quality, accessibility, and affordability of healthcare through advanced technology. Founded in 2010 in Coralville, Iowa, by Michael Abramoff, the company has developed a range of autonomous algorithms that analyze medical images to detect various diseases. Its flagship products include IDx-DR for diabetic retinopathy, IDx-G for glaucoma indicators, and IDx-AMD for age-related macular degeneration. Additionally, Digital Diagnostics provides algorithms for detecting other conditions such as Alzheimer's disease and cardiovascular risks. By eliminating the diagnostic burden from specialists, the company's AI platform aims to establish a new standard of care, democratizing healthcare and improving patient outcomes. The company collaborates with patient advocacy groups and regulatory bodies to facilitate the adoption of its innovative solutions both in the United States and internationally.
BigHat Biosciences
Series B in 2022
BigHat is a developer of an AI-guided protein therapeutic platform used to integrate antibody characterization lab with machine learning technologies to engineer molecules with more complex functions and better biophysical properties. The company is applying these design capabilities to develop new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases.
Unlearn.AI
Series B in 2022
Unlearn.AI, Inc. is a biotechnology company that specializes in developing software tools for clinical research, focusing on improving diagnosis and treatment processes. Based in San Francisco, the company offers solutions such as Clinical Trial Design, which helps define inclusion criteria, endpoints, and study sizes; Synthetic Control Arms, which reduce or eliminate the necessity for concurrent control groups; and Subgroup Analysis, which identifies specific patient subgroups within trial results. Unlearn.AI has pioneered the TwinRCT solution, a digital twin service that leverages machine learning to enhance the efficiency and success rates of clinical trials. This innovative approach creates a prognostic digital twin for each patient, allowing for more precise estimations of treatment effects based on historical data. By integrating machine learning and biostatistics, Unlearn.AI aims to accelerate the clinical trial process, benefiting both patients and pharmaceutical sponsors.
Candid Health
Series A in 2022
Candid Health is a platform that automates revenue cycle management for healthcare providers, facilitating efficient tracking of claims and management of billing processes. Utilizing machine learning and artificial intelligence, the platform streamlines medical billing, coding, and claims processing, thereby reducing administrative burdens and enhancing operational efficiency. By offering end-to-end automation, Candid Health optimizes financial operations for clinics and hospitals, allowing healthcare providers to concentrate on delivering quality, affordable, and accessible care while ensuring faster service reimbursement. The platform seamlessly integrates with existing systems, providing modern tools that simplify the complexities of medical billing and improve overall patient experiences.
Ponder
Seed Round in 2022
Ponder Data Inc. provides enterprise-ready tools for rapid, flexible experimentation with data at scale. Ponder makes data teams more productive by enabling them to get insights faster with tools they know and love.
Metaphysic
Seed Round in 2022
Metaphysic is a developer of software focused on the creation of synthetic media, aiming to enhance human expression through ethical applications. The company's technology reconstructs low-resolution video footage and generates realistic facial representations, allowing users to edit expressions and facial features seamlessly. This innovative approach enables content creators to produce immersive and realistic experiences in various media, particularly within the metaverse. By leveraging artificial intelligence, Metaphysic provides tools that expand the creative possibilities for artists and filmmakers, ensuring a natural and engaging interaction with digital content.
Wispr Flow
Seed Round in 2021
Think it, speak it, send it. Effortless voice dictation for Mac and now Windows!
Spartan Radar
Series A in 2021
Spartan Radar specializes in advanced radar technology that creates high-resolution real-time imagery, utilizing proprietary software algorithms that incorporate machine learning and edge-processing. By mimicking human sensory perception, Spartan's solutions enhance the performance of existing advanced driver-assistance systems (ADAS) by improving resolution, response time, and range while maintaining low computational demands. The company's expertise in signal processing, developed through years of experience in the aerospace and automotive sectors, enables it to offer cost-effective sensing solutions. Spartan's platform is applicable across various industries, including drone and automotive applications, positioning the company as a leader in innovative radar technology.
Immunai
Series B in 2021
Immunai Inc. is a biotechnology company that specializes in immune profiling through its artificial intelligence-based platform, which combines single-cell genomics and machine learning. Founded in 2018 and headquartered in New York City, with additional offices in San Francisco and Tel Aviv, Immunai aims to map the immune system comprehensively. Its technology allows for high-resolution profiling of immune cells from blood samples, enabling the identification of numerous cell types and their states. This approach generates valuable biological insights that support drug development, particularly in oncology and autoimmune disorders. The company collaborates with academic institutions, biopharmaceutical firms, and biotechnology companies to drive research in areas such as cancer therapy and vaccines.
Pave
Seed Round in 2021
Pave helps consumer and SMB credit risk teams increase approvals through AI-powered cashflow analytics. 100 million+ US consumers and businesses are financially underserved, simply because their data is not recognized by the traditional financial system. We solve this by transforming transaction data, loan performance outcomes, and credit reports into Cashflow-driven Attributes and Scores, enabling increased financial access to new customer segments without increasing risk. Our mission is to build a future where every person and business has access to equitable credit solutions by creating a new standard of Cashflow-driven Analytics.
Unstruk Data
Seed Round in 2021
Unstruk Data was started on the premise that expert domain knowledge is being lost at an alarming rate, as employees leave and projects end. For companies that manage and track real-world assets, as the volume of their acquired spatial and unstructured data rises, the amount of hidden or "dark" data increases even more rapidly. Unstruk offers a full-stack knowledge platform which leverages no-code machine learning and a user-friendly spatial data analytics interface. With the Unstruk Data Portal, geo-enabled businesses can catalog, correlate and search their video, audio, 3D point clouds, shape files, orthographic images, PDFs, emails (and more) - to make data-driven decisions more easily and without coding required. Data can be further enriched and correlated via external integrations with ESRI ArcGIS, satellite imagery providers, databases and other API-based services.
Deliverr
Series D in 2021
Deliverr, Inc. is a San Francisco-based company founded in 2017 that specializes in order fulfillment services for e-commerce retailers. The company provides shipping solutions designed to help online businesses meet shipping standards and avoid penalties associated with late shipments. By leveraging machine learning and predictive intelligence, Deliverr's platform enables sellers to offer various shipping options and access services such as warehousing, order handling, and packaging. This tech-enabled approach allows sellers of all sizes to fulfill orders efficiently, improve customer satisfaction, and expand their market reach through fast and cost-effective fulfillment solutions.
Deliverr
Convertible Note in 2021
Deliverr, Inc. is a San Francisco-based company founded in 2017 that specializes in order fulfillment services for e-commerce retailers. The company provides shipping solutions designed to help online businesses meet shipping standards and avoid penalties associated with late shipments. By leveraging machine learning and predictive intelligence, Deliverr's platform enables sellers to offer various shipping options and access services such as warehousing, order handling, and packaging. This tech-enabled approach allows sellers of all sizes to fulfill orders efficiently, improve customer satisfaction, and expand their market reach through fast and cost-effective fulfillment solutions.
BigHat Biosciences
Series A in 2021
BigHat is a developer of an AI-guided protein therapeutic platform used to integrate antibody characterization lab with machine learning technologies to engineer molecules with more complex functions and better biophysical properties. The company is applying these design capabilities to develop new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases.
Flywheel.io
Series B in 2021
Flywheel.io is a cloud-based data management platform tailored for biomedical research and collaboration. Founded in 2012 and headquartered in Minneapolis, Minnesota, the company provides a suite of tools designed to enhance the workflow of scientists and researchers. Its platform supports medical imaging, scientific computation, and content management, enabling users to capture, manage, and analyze research data efficiently. By utilizing cloud scalability and automation, Flywheel facilitates collaborative research, machine learning applications, and multicenter studies, which help organizations streamline their research processes. The platform, featuring a modern web interface and extensible compute engine, aims to eliminate bottlenecks in innovation, allowing researchers to focus on scientific discovery rather than IT challenges.
Model Medicines
Pre Seed Round in 2021
Model Medicines uses human expertise and AI to accelerate the development of life-changing drugs at scale. Model Medicines harnesses AI and ML with its ActivPred AI Drug Discovery Platform to discover drugs that may be repositioned to serve as therapeutics to treat patients suffering from humankind’s toughest diseases. The drugs that Model Medicines discovers can enter clinical trials in as little as several months.
Atomic AI
Seed Round in 2021
Atomic AI is focused on advancing RNA drug discovery through the integration of machine learning and structural biology. The company operates a content intelligence platform that facilitates the rational design of new molecules and medicines. By leveraging engagement data from clients' analytics, Atomic AI gathers insights to create predictive reports on various topics, including optimal publishing times and distribution channels. This approach equips users with innovative strategies to develop treatments or cures for diseases by specifically targeting RNA structures.
LightBeam.ai
Seed Round in 2020
LightBeam.ai is a leader in data security and privacy automation, dedicated to helping organizations manage and access sensitive information securely. The company offers a platform that utilizes advanced data management, entity linkage techniques, and deep learning to analyze documents, speech, and natural language processing at scale. This technology integrates seamlessly with various data sources across industries, enabling clients to derive actionable insights while maintaining data privacy and confidentiality. By providing a unified control tower for data cataloging, access, and sharing, LightBeam empowers privacy and compliance executives to ensure continuous compliance, while information security professionals can trust that sensitive data is accessed and utilized securely.
Unlearn.AI
Series A in 2020
Unlearn.AI, Inc. is a biotechnology company that specializes in developing software tools for clinical research, focusing on improving diagnosis and treatment processes. Based in San Francisco, the company offers solutions such as Clinical Trial Design, which helps define inclusion criteria, endpoints, and study sizes; Synthetic Control Arms, which reduce or eliminate the necessity for concurrent control groups; and Subgroup Analysis, which identifies specific patient subgroups within trial results. Unlearn.AI has pioneered the TwinRCT solution, a digital twin service that leverages machine learning to enhance the efficiency and success rates of clinical trials. This innovative approach creates a prognostic digital twin for each patient, allowing for more precise estimations of treatment effects based on historical data. By integrating machine learning and biostatistics, Unlearn.AI aims to accelerate the clinical trial process, benefiting both patients and pharmaceutical sponsors.
BigHat Biosciences
Seed Round in 2019
BigHat is a developer of an AI-guided protein therapeutic platform used to integrate antibody characterization lab with machine learning technologies to engineer molecules with more complex functions and better biophysical properties. The company is applying these design capabilities to develop new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases.
Levee
Seed Round in 2019
Levee is a technology company based in São Paulo, Brazil, founded in 2016. It has developed a platform that leverages artificial intelligence and machine learning to connect informal, unskilled workers with formal job opportunities that offer greater security and higher pay. The company's solutions cater to C-Level executives and human resources professionals across various sectors, including retail, food services, and healthcare. Levee's approach combines data science, automation, and recruitment marketing to streamline the hiring process for frontline workers. By enhancing efficiency and productivity, Levee aims to reduce absenteeism and improve overall employee engagement and turnover rates, enabling businesses to build a more effective workforce.
People Data Labs
Series A in 2018
People Data Labs specializes in providing high-quality B2B data for developers, engineers, and data scientists. With a robust database of 3 billion accurate records, the company enables clients to create and enhance person profiles, enrich existing data, and support predictive modeling and artificial intelligence applications. Their platform serves various sectors, including sales and marketing, investment research, fraud detection, and talent acquisition, ensuring that clients can build and scale innovative, data-driven products effectively. By acting as a reliable data partner, People Data Labs supports both enterprise and startup clients in achieving greater efficiency and success in their data-enabled initiatives.
Deliverr
Series A in 2018
Deliverr, Inc. is a San Francisco-based company founded in 2017 that specializes in order fulfillment services for e-commerce retailers. The company provides shipping solutions designed to help online businesses meet shipping standards and avoid penalties associated with late shipments. By leveraging machine learning and predictive intelligence, Deliverr's platform enables sellers to offer various shipping options and access services such as warehousing, order handling, and packaging. This tech-enabled approach allows sellers of all sizes to fulfill orders efficiently, improve customer satisfaction, and expand their market reach through fast and cost-effective fulfillment solutions.
Digital Diagnostics
Series A in 2018
Digital Diagnostics Inc. is an artificial intelligence diagnostics company focused on enhancing the quality, accessibility, and affordability of healthcare through advanced technology. Founded in 2010 in Coralville, Iowa, by Michael Abramoff, the company has developed a range of autonomous algorithms that analyze medical images to detect various diseases. Its flagship products include IDx-DR for diabetic retinopathy, IDx-G for glaucoma indicators, and IDx-AMD for age-related macular degeneration. Additionally, Digital Diagnostics provides algorithms for detecting other conditions such as Alzheimer's disease and cardiovascular risks. By eliminating the diagnostic burden from specialists, the company's AI platform aims to establish a new standard of care, democratizing healthcare and improving patient outcomes. The company collaborates with patient advocacy groups and regulatory bodies to facilitate the adoption of its innovative solutions both in the United States and internationally.
Alloy.ai
Series A in 2018
Alloy.ai is a demand and inventory control platform designed to assist consumer goods brands in optimizing their supply chain operations. By providing daily insights at the SKU-store level, Alloy.ai enables brands to swiftly identify and address issues, enhancing their responsiveness to market changes. The platform integrates over 850 pre-built connectors that combine point-of-sale and inventory data with supply chain information, offering comprehensive visibility across networks. This capability allows brands to predict challenges that competitors may overlook. Trusted by a range of companies, from Fortune 500 firms to emerging digital brands, Alloy.ai helps clients achieve significant improvements, including over 35% reductions in out-of-stock situations and notable increases in their bottom line.
LocateAI
Venture Round in 2018
LocateAI is using geospatial data and machine learning to transform the antiquated, $4T real estate industry. Founded by Stanford computer scientists, the team is building a predictive analytical platform that generates unique insights on how to make smarter and faster transactions. Our forecasts are custom-tailored and backed by millions of data points. Our core technologies include data mining, machine learning, and data visualization.
MindBridge
Series A in 2018
MindBridge Analytics Inc. is a Canadian FinTech company that offers financial analytics software designed for audit, assurance, and commercial enterprises. Utilizing machine learning and artificial intelligence, the MindBridge platform identifies unusual patterns of activities, unintentional errors, and potential financial misstatements within financial datasets. By generating risk-weighted analyses and deep insights into monetary flows, the software helps organizations across various industries enhance their controls, minimize financial losses, and improve decision-making processes.
Forethought
Seed Round in 2018
Forethought, founded in 2018, specializes in generative AI solutions aimed at enhancing customer service automation. The company offers tools that improve efficiency by integrating AI, particularly Large Language Models, into various stages of the customer support process. These tools facilitate immediate responses to customer inquiries, automate the handling of routine issues, and assist support agents with relevant information. By streamlining workflows and providing actionable insights, Forethought enables businesses to reduce resolution times and boost agent productivity, ultimately creating a more seamless customer experience.
PathAI
Series A in 2017
PathAI, Inc. is a company that develops artificial intelligence-based technology solutions aimed at enhancing the accuracy and efficiency of pathology laboratories. Founded in 2016 and headquartered in Boston, Massachusetts, with an additional office in Austin, Texas, PathAI's platform utilizes machine and deep learning techniques to process large datasets, enabling pathologists to diagnose cancer and other conditions rapidly and accurately. The technology not only assists in making precise diagnoses but also identifies patients who may benefit from innovative therapies, thereby facilitating personalized medicine. PathAI addresses complex challenges in pathology for both the research and pharmaceutical industries, providing reliable and scalable solutions.
Knowde
Pre Seed Round in 2017
Knowde operates an online marketplace focused on the chemical industry, enhancing the accessibility of trading chemicals, polymers, and industrial ingredients. Its platform utilizes advanced technologies, including deep learning and self-learning data models, to facilitate the search, filtering, sampling, quoting, and purchasing of products tailored to client specifications. By offering a comprehensive chemical taxonomy, Knowde empowers global chemical producers and distributors to transform their operations digitally. This innovative approach allows clients to compare and access products from suppliers worldwide, streamlining the procurement process in the chemical sector. The company has garnered support from prominent investors, highlighting its potential in revolutionizing how chemical transactions are conducted.
MindBridge
Seed Round in 2017
MindBridge Analytics Inc. is a Canadian FinTech company that offers financial analytics software designed for audit, assurance, and commercial enterprises. Utilizing machine learning and artificial intelligence, the MindBridge platform identifies unusual patterns of activities, unintentional errors, and potential financial misstatements within financial datasets. By generating risk-weighted analyses and deep insights into monetary flows, the software helps organizations across various industries enhance their controls, minimize financial losses, and improve decision-making processes.
People Data Labs
Series A in 2017
People Data Labs specializes in providing high-quality B2B data for developers, engineers, and data scientists. With a robust database of 3 billion accurate records, the company enables clients to create and enhance person profiles, enrich existing data, and support predictive modeling and artificial intelligence applications. Their platform serves various sectors, including sales and marketing, investment research, fraud detection, and talent acquisition, ensuring that clients can build and scale innovative, data-driven products effectively. By acting as a reliable data partner, People Data Labs supports both enterprise and startup clients in achieving greater efficiency and success in their data-enabled initiatives.
Hive
Series A in 2016
Hive is a San Francisco-based company that specializes in cloud-based artificial intelligence solutions aimed at enhancing business processes through deep learning and computer vision. It offers a range of products, including Hive Media, an analytics platform for broadcasters and advertisers; Hive Security, which provides video analytics and visual intelligence software; Hive Auto, focusing on visual perception for autonomous vehicles; and Hive Retail, which delivers custom deep learning solutions for retail operations. With a significant portfolio of pre-trained AI models, Hive supports billions of API requests monthly and addresses critical business needs such as content moderation, brand protection, and ad targeting. The company has raised substantial capital from prominent investors and employs over 175 full-time staff, complemented by a global network of contributors for data labeling operations. Hive was incorporated in 2013 and has established itself as a leader in AI technology for diverse enterprise applications.
Alloy.ai
Seed Round in 2016
Alloy.ai is a demand and inventory control platform designed to assist consumer goods brands in optimizing their supply chain operations. By providing daily insights at the SKU-store level, Alloy.ai enables brands to swiftly identify and address issues, enhancing their responsiveness to market changes. The platform integrates over 850 pre-built connectors that combine point-of-sale and inventory data with supply chain information, offering comprehensive visibility across networks. This capability allows brands to predict challenges that competitors may overlook. Trusted by a range of companies, from Fortune 500 firms to emerging digital brands, Alloy.ai helps clients achieve significant improvements, including over 35% reductions in out-of-stock situations and notable increases in their bottom line.
Crunchbase
Series A in 2015
Crunchbase is a comprehensive platform that assists over 80 million investors, analysts, and dealmakers in identifying and acting on private market opportunities through detailed analysis of company activities. It enables users to discover significant companies via its homepage, Crunchbase Scout, and search functionalities. The platform offers proprietary predictions and insights on organizational profiles, facilitating informed decision-making. Additionally, Crunchbase enhances team efficiency with various features such as data exports, administrative tools, and integrations. By providing unique private company intelligence, Crunchbase bridges the gap between data access and actionable business decisions, ultimately supporting users in navigating the complexities of the investment landscape.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.